| Therapeutic Effect of Herbal Infusion on Menometrorrhagia (NCT05406960) | Faculty of Medicine, Sousse | 2019-05-10 |
| Acceptability and Tolerance of Hysteroscopy and Hysterosonography in Consultation (NCT03121560) | Brugmann University Hospital | 2017-11-14 |
| Cooperative Adenomyosis Network (NCT03230994) | Peking Union Medical College Hospital | 2017-06-30 |
| Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS) (NCT02824224) | Oregon Health and Science University | 2016-09-06 |
| Evaluation of the Performance of a Rapid Pregnancy Diagnostic Test. (NCT03250884) | Rennes University Hospital | 2016-08-30 |
| Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users (NCT02311478) | University of Utah | 2014-12-01 |
| Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol (NCT01557023) | Eurofarma Laboratorios S.A. | 2013-07-01 |
| Controlled Trial of Tele-Support and Education for Womens Health Care in CBOCs (NCT01918072) | VA Office of Research and Development | 2013-03-01 |
| Surgical Success After Laparoscopic vs Abdominal Hysterectomy (NCT01793584) | University of Texas Southwestern Medical Center | 2013-02-01 |
| Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment (NCT01647360) | Abbott | 2012-06-01 |
| Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding (NCT01638923) | Bayer | 2012-06-01 |
| A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions. (NCT01436513) | Pfizer | 2011-10-01 |
| Minimally Invasive Benign Hysterectomy (NCT01865929) | Region Skane | 2010-01-01 |
| Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation (NCT00563576) | Columbia University | 2007-09-01 |
| Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding (NCT00307801) | Bayer | 2006-02-01 |
| Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding (NCT00293059) | Bayer | 2005-12-01 |
| Study of Asoprisnil in the Treatment of Uterine Fibroids. (NCT00156156) | Abbott | 2004-11-01 |
| Safety of Treatment of Uterine Fibroids With Asoprisnil (NCT00156208) | Abbott | 2004-04-01 |
| An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen (NCT00344383) | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | 2003-11-01 |
| A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids (NCT00152256) | Abbott | 2003-09-01 |
| A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids (NCT00160381) | Abbott | 2002-09-01 |
| Treatment of Uterine Fibroids With Asoprisnil(J867) (NCT00152269) | Abbott | 2002-07-01 |
| An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen (NCT00320580) | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | |